| 2-AG | 2-Arachidonoylglycerol |
| 5-HT | Serotonin |
| A(+) | alcohol’s +ve effects |
| A(−) | alcohol’s −ve effects |
| AA | arachidonic acid |
| AC | adenylyl cyclase |
| ACh | Acetylcholine |
| AChergic | ACh releasing neurons |
| ADH | alcohol dehydrogenase |
| ALDH | acetaldehy6de dehydrogenase |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| AUC | area under curve |
| AUD | alcohol use disorder |
| cAMP | cyclic adenosine monophosphate |
| CL | clearance |
| Cmax | maximum concentration |
| COMT | catechol-O-methyl-transferase |
| COX | Cyclooxygenase |
| CYP | cytochrome P450 |
| DA | Dopamine |
| DA | dopamine} |
| DAG | Diacylglycerol |
| DAGL | diacylglycerol lipase |
| DAR1 | dopamine receptor 1 |
| DAT | dopamine transporter |
| DOR | delta OPRs |
| DPDEP | D-Pen2, D-Pen5 enkephalin, DOR agonist |
| EAA | excitatory amino acids |
| eCB | Endocannabinoid |
| eOP | endogenous opioids |
| ERK | extracellular-signal-regulated kinase |
| GABA | γ-aminobutyric acid |
| GABABR | GABA B receptor |
| GABAergic | GABA releasing neurons |
| GHB | γ-hydroxybutyric acid |
| GHBD | GHB dehydrogenase |
| GIRK | G protein-coupled inwardly-rectifying potassium channels |
| Glu | Glutamate |
| Gluergic | glutamate releasing neurons |
| Gly | Glycine |
| IP3 | inositol trisphosphate |
| KOR | kappa OPRs |
| LDTg | laterodorsal tegmental nucleus |
| LPS | Lipopolysaccharide |
| METH | Methamphetamine |
| mGluR2/3 | metabolic Glu receptors 2/3 |
| MOR | mu OPRs |
| NAc | nucleus accumbens |
| nAChR | nicotinic ACh receptor |
| NAPQI | N-acetyl-p-benzoquinone imine |
| NE | Noradrenaline |
| NMDA | N-methyl-d-Aspartate receptors |
| OP | Opioid |
| OPR | opioid receptors |
| OPRM1 | A118G variant of the MOR1 |
| PIP2 | poly inositol diphosphate |
| pptg | pedunculopontine tegmental nucleus |
| SERT | serotonin transporter |
| sOP | synthetic opioids |
| SSA | succinic semialdehyde |
| T | elimination half-life |
| THC | Δ9-Tetrahydrocannabinol |
| tmax | time to Cmax |
| TMU | 1,3,7-trimethyluric acid |
| U50488H | KOR agonist |
| VGSC | voltage gated sodium ion (Na+) channel |
| VGCC | voltage gated calcium ion (Ca2+) channel |
| VTA | ventral tegmental area |
| α7 and α4β2 | nicotinic receptor subtypes |